stella
beta
Adjuvant Treatment of Patients With High Risk of Recurrent Hepatocellular Carcinoma With Donafenib in Combination With Envafolimab — Stella
Recruiting
Back to Hepatocellular Carcinoma trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(2 sites)
China
No.2 People's Hospital of Fuyang city, Fuyang, Anhui
Anhui province hospital, Hefei, Anhui
View full record on ClinicalTrials.gov